Manganese-DPDP as a Hepatobiliary Contrast Agent in the Magnetic Resonance Imaging of Liver Tumors: Results of Clinical Phase II Trials in Germany Including 141 Patients (Q67881968)
Jump to navigation
Jump to search
scientific article published on 01 November 1991
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Manganese-DPDP as a Hepatobiliary Contrast Agent in the Magnetic Resonance Imaging of Liver Tumors: Results of Clinical Phase II Trials in Germany Including 141 Patients |
scientific article published on 01 November 1991 |
Statements
Manganese-DPDP as a hepatobiliary contrast agent in the magnetic resonance imaging of liver tumors. Results of clinical phase II trials in Germany including 141 patients (English)
Manganese-DPDP as a Hepatobiliary Contrast Agent in the Magnetic Resonance Imaging of Liver Tumors: Results of Clinical Phase II Trials in Germany Including 141 Patients (English)
1 reference
E. Rummeny
C. Ehrenheim
H. B. Gehl
B. Hamm
M. Laniado
K. P. Lodemann
E. Schmiedel
A. Steudel
1 November 1991
S142-5; discussion S150-5